ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $23,503,000 | -20.2% | 30,000,000 | -12.8% | 0.03% | -21.6% |
| Q2 2019 | $29,469,000 | +2.5% | 34,409,000 | +6.2% | 0.04% | 0.0% |
| Q1 2019 | $28,756,000 | +69.1% | 32,409,000 | +58.4% | 0.04% | +60.9% |
| Q4 2018 | $17,010,000 | +50.5% | 20,459,000 | +54.0% | 0.02% | +64.3% |
| Q3 2018 | $11,299,000 | +44.5% | 13,282,000 | +64.1% | 0.01% | +40.0% |
| Q2 2018 | $7,819,000 | -26.4% | 8,092,000 | -30.2% | 0.01% | -28.6% |
| Q1 2018 | $10,627,000 | +17.6% | 11,592,000 | +9.4% | 0.01% | +16.7% |
| Q4 2017 | $9,035,000 | -33.3% | 10,592,000 | -29.4% | 0.01% | -42.9% |
| Q3 2017 | $13,540,000 | +5.0% | 15,000,000 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $12,892,000 | +0.7% | 15,000,000 | 0.0% | 0.02% | -8.7% |
| Q1 2017 | $12,801,000 | -1.1% | 15,000,000 | -11.8% | 0.02% | +4.5% |
| Q4 2016 | $12,946,000 | +26.6% | 17,000,000 | +36.0% | 0.02% | +22.2% |
| Q3 2016 | $10,225,000 | – | 12,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,586,000 | $3,237,000 | 2.17% |
| Telemetry Investments, L.L.C. | 4,000,000 | $3,610,000 | 1.29% |
| Castle Creek Arbitrage, LLC | 6,000,000 | $5,419,000 | 0.54% |
| Man Investments (CH) AG | 600,000 | $542,000 | 0.46% |
| SSI INVESTMENT MANAGEMENT LLC | 5,683,000 | $5,129,000 | 0.44% |
| CANYON CAPITAL ADVISORS LLC | 29,000,000 | $26,173,000 | 0.39% |
| PFM Health Sciences, LP | 21,362,000 | $19,386,000 | 0.38% |
| IRON Financial LLC | 500,000 | $454,000 | 0.35% |
| Partner Investment Management, L.P. | 373,000 | $338,000 | 0.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 29,555,000 | $26,667,000 | 0.30% |